The prospective screening for SARS-CoV-2 S1/S2 antibodies delineates the factual incidence of COVID-19 and shows a sustained serological response post COVID-19 in kidney transplant recipients.
Louis FirketAntoine BouquegneauLaurence SeidelCatherine BonvoisinStéphanie GroschMarie-Pierre HayetteFrançois JouretLaurent WeekersPublished in: Acta clinica Belgica (2022)
COVID-19, which most often persists beyond 9 months.